BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37783911)

  • 21. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.
    Bagante F; Tran T; Spolverato G; Ruzzenente A; Buttner S; Ethun CG; Groot Koerkamp B; Conci S; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Vitiello G; IJzermans JN; Maithel SK; Poultsides G; Guglielmi A; Pawlik TM
    J Am Coll Surg; 2016 May; 222(5):750-759.e2. PubMed ID: 27113512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
    Huang S; Song JL; Li B; Yi PS; Yang J
    BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of lymph nodes during resection of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review.
    Amini N; Ejaz A; Spolverato G; Maithel SK; Kim Y; Pawlik TM
    J Gastrointest Surg; 2014 Dec; 18(12):2136-48. PubMed ID: 25300798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma.
    Guglielmi A; Ruzzenente A; Campagnaro T; Valdegamberi A; Bagante F; Bertuzzo F; Conci S; Iacono C
    J Gastrointest Surg; 2013 Nov; 17(11):1917-28. PubMed ID: 24048613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma.
    Zhang XF; Chakedis J; Bagante F; Chen Q; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    Br J Surg; 2018 Jun; 105(7):857-866. PubMed ID: 29656380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W; Jeong CY; Jang JY; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Ryu JH; Yang K; Choi CS; Park YH; Nah YW; Kim R; Navarro J; Han DH; Choi GH; Kang CM; Kim KS; Hong SC
    Eur J Surg Oncol; 2020 May; 46(5):832-838. PubMed ID: 31806519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Pawlik TM
    Ann Surg Oncol; 2023 Apr; 30(4):1966-1977. PubMed ID: 36622527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].
    Chen C; Wu YH; Li Q; Wu H; Qiu YH; Song TQ; Mao XH; He Y; Cheng Z; Zhai WL; Li JD; Geng ZM; Tang ZH
    Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):295-302. PubMed ID: 32241060
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    J Gastrointest Surg; 2018 Jan; 22(1):52-59. PubMed ID: 28424987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
    Xiao J; Zhu J; Liu Z; Wan R; Li Y; Xiao W
    J Cancer Res Ther; 2017; 13(5):756-760. PubMed ID: 29237899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical strategy for incidental intrahepatic cholangiocarcinoma in terms of lymph node dissection.
    Kim SH; Han DH; Choi GH; Choi JS; Kim KS
    J Gastrointest Surg; 2024 Jun; 28(6):910-915. PubMed ID: 38561087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis.
    Zhang XF; Xue F; Dong DH; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Itaru E; Lv Y; Pawlik TM
    Ann Surg; 2021 Dec; 274(6):e1187-e1195. PubMed ID: 31972643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node dissection for intrahepatic cholangiocarcinoma: a critical review of the literature to date.
    Adachi T; Eguchi S
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):162-8. PubMed ID: 24027075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma Patients With Clinically Negative Lymph Node Metastasis: A Multi-Center Study From China.
    Ke Q; Wang L; Lin Z; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Front Oncol; 2021; 11():585808. PubMed ID: 33777738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database.
    Clark CJ; Wood-Wentz CM; Reid-Lombardo KM; Kendrick ML; Huebner M; Que FG
    HPB (Oxford); 2011 Sep; 13(9):612-20. PubMed ID: 21843261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
    Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.